Rep. Robert Bresnahan, Jr. Sells HealthEquity, Inc. (NASDAQ:HQY) Shares

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of HealthEquity, Inc. NASDAQ: HQY. In a filing disclosed on February 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in HealthEquity stock on January 13th. The trade occurred in the Representative's "JOINT OWNERSHIP LPL ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of Lowe's Companies NYSE: LOW on 2/7/2025.
• Purchased $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 2/3/2025.
• Purchased $1,001 - $15,000 in shares of Take-Two Interactive Software NASDAQ: TTWO on 2/3/2025.
• Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 2/3/2025.
• Purchased $1,001 - $15,000 in shares of Alibaba Group NYSE: BABA on 1/30/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 1/30/2025.
• Sold $1,001 - $15,000 in shares of Robinhood Markets NASDAQ: HOOD on 1/29/2025.
• Sold $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 1/29/2025.
• Sold $1,001 - $15,000 in shares of Manhattan Associates NASDAQ: MANH on 1/29/2025.
• Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 1/29/2025.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $0.19 during trading on Tuesday, reaching $112.88. 46,218 shares of the company traded hands, compared to its average volume of 734,568. The firm has a 50 day simple moving average of $102.38 and a 200-day simple moving average of $91.18. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock has a market capitalization of $9.78 billion, a PE ratio of 103.68, a P/E/G ratio of 1.61 and a beta of 0.55. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the company posted $0.40 earnings per share. Equities research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company's stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,000 shares of company stock worth $3,895,788 over the last quarter. Company insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HQY. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. BTIG Research increased their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. Bank of America upped their price target on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. Finally, JMP Securities raised their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $110.71.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Arcadia Investment Management Corp MI bought a new position in shares of HealthEquity during the 4th quarter valued at approximately $26,000. Transce3nd LLC purchased a new position in HealthEquity during the fourth quarter worth $29,000. Smartleaf Asset Management LLC increased its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after acquiring an additional 98 shares during the last quarter. Proficio Capital Partners LLC bought a new position in HealthEquity during the 4th quarter valued at about $39,000. Finally, UMB Bank n.a. grew its stake in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.